In both obese and non-obese subgroups, ASA III/IV status was associated with a greater risk for sedation-related adverse events (OR 3.75, 95%CI 0.63-22.04 and OR 5.42, 95%CI 0.42-69.67, respectively), though these differences did not reach statistical significance.
← all excerpts
Risk factors for sedation-related adverse events during endoscopic ultrasound.
1
—
—